跳至主要内容
临床试验/NCT06602284
NCT06602284尚未招募2 期

A Full Face, Baseline Controlled Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Conjunction with MG-CLR Serum for Acne Treatment Over 12 Weeks.

Equipmed USA LLC2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年10月1日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
10
试验地点
2
主要终点
Acne severity

研究概览

简要总结

This study is conducted to check how well the Dermapen 4™ microneedling device works with MG-CLR serum for treating acne over 12 weeks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female subjects aged between 18-45 years (both ages inclusive)
  • Fitzpatrick skin phototype I to VI.
  • Subjects having IGA score of 2 and
  • Subjects who have not received any kind of treatment for acne 1 month before the start of the study.
  • Subject free of excessive hair, cuts, abrasions, fissures, wounds, lacerations, or any other skin conditions on the face.
  • Subjects who agree not to use any other product/treatment/home remedy/ except the provided products on their face during the study period

排除标准

  • Subjects with known skin condition that may impact the assessment.
  • Subjects with active Herpes labialis infection.
  • Subjects known to have bleeding and clotting disorders (self-declared).
  • Subjects known to have connective tissue disorders.
  • Subjects with any other signs of significant local irritation or skin disease.
  • Subjects currently taking any medication, which the investigator believes may influence the interpretation of the data.

结局指标

主要结局

Acne severity

时间窗: 13 weeks

Change in acne severity using the modified GAGS scale at all time points when compared to baseline.

次要结局

未报告次要终点

研究者

发起方
Equipmed USA LLC
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验